Equillium Inc EQ:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 12:16 PM EDT
6.80quote price arrow up+0.28 (+4.29%)
Volume
77,204
52 week range
3.47 - 11.33
Loading...
  • Open6.50
  • Day High6.88
  • Day Low6.26
  • Prev Close6.52
  • 52 Week High11.33
  • 52 Week High Date02/12/21
  • 52 Week Low3.47
  • 52 Week Low Date11/10/20

Key Stats

  • Market Cap199.78M
  • Shares Out29.38M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.62
  • YTD % Change27.1

KEY STATS

  • Open6.50
  • Day High6.88
  • Day Low6.26
  • Prev Close6.52
  • 52 Week High11.33
  • 52 Week High Date02/12/21
  • 52 Week Low3.47
  • 52 Week Low Date11/10/20
  • Market Cap199.78M
  • Shares Out29.38M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.62
  • YTD % Change27.1

RATIOS/PROFITABILITY

  • EPS (TTM)-1.31
  • P/E (TTM)-5.18
  • Fwd P/E (NTM)-4.64
  • EBITDA (MRQ)-35.86M
  • ROE (MRQ)-58.17%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)11.88%

EVENTS

  • Earnings Date11/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Equillium Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Equillium, Inc. is a biotechnology company. The Company develops products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. Its initial product candidate, EQ001 (itolizumab), is a clinical-stage, monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. CD6 plays a central role in the modulation of effector T cells, or Teff cells. Activated Teff cells drive a number of immuno-inflammatory...
Daniel Bradbury
Chairman
Bruce Steel
President
Christine Zedelmayer
Chief Operating Officer
Jason Keyes
Chief Financial Officer
Dolca Thomas M.D.
Executive Vice President
Address
2223 Avenida de La Playa Ste 105
La Jolla, CA
92037-3217
United States

Top Peers

SYMBOLLASTCHG%CHG
GRTX
Galera Therapeutics Inc
7.39-0.07-0.94%
NXTC
NextCure Inc
6.82-0.08-1.16%
LRMR
Larimar Therapeutics Inc
12.35+1.05+9.29%
TYME
Tyme Technologies Inc
1.02+0.02+2.00%
TFFP
TFF Pharmaceuticals Inc
8.22+0.02+0.24%